Human Abuse Liability Assessment of Tobacco and Nicotine Products: Approaches for Meeting Current Regulatory Recommendations

被引:11
|
作者
Vansickel, Andrea [1 ]
Baxter, Sarah [2 ]
Sherwood, Neil
Kong, Michael [3 ]
Campbell, Leanne [2 ]
机构
[1] Altria Client Serv LLC, Regulatory Affairs, Richmond, VA 23225 USA
[2] RAI Serv Co, Clin Studies, Winston Salem, NC USA
[3] Altasci Clin Res, Montreal, PQ, Canada
关键词
REDUCED EXPOSURE PRODUCTS; ELECTRONIC CIGARETTE; COMBUSTIBLE CIGARETTES; REINFORCING EFFICACY; INTRAVENOUS NICOTINE; DELIVERY; PHARMACOKINETICS; DISCRIMINATION; SMOKERS; VALIDATION;
D O I
10.1093/ntr/ntab183
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Many regulatory bodies now recommend that tobacco product manufacturers provide information regarding new tobacco products' abuse liability to inform regulatory authorization of currently marketed tobacco products or new product applications (including premarket tobacco product applications in the United States). In addition, the US Food and Drug Administration (FDA) recommends including this information as part of modified risk tobacco product applications. Regulators, including FDA, and many public health officials and researchers consider abuse liability assessment a model which predicts the likelihood that the use of the tobacco product would result in addiction and be used repeatedly or even sporadically resulting in undesirable effects. Abuse liability of a new, potentially reduced harm product can also inform its ability to substitute completely for more harmful tobacco products. While many methods exist, no standard tobacco product abuse liability assessment has been established. The purpose of this review is to provide background information and practical recommendations for human abuse liability testing methods to meet tobacco regulatory needs. A combination of nicotine test product pharmacokinetic, subjective effect and/or behavioral response, and physiological response data relative to comparator products with known abuse liability satisfies some regulatory requirements. Implications: This review provides a practical inspection of the current, international regulatory recommendations for abuse liability assessment of tobacco and regulatory review of such information within the United States and also recommends study designs and methods for abuse liability testing of tobacco products based on scientific and regulatory knowledge. Given that tobacco product abuse liability testing is of increasing interest to regulatory bodies globally, especially with the emergence of novel tobacco products, this timely work provides background and functional recommendations for tobacco product abuse liability testing.
引用
收藏
页码:295 / 305
页数:11
相关论文
共 50 条
  • [1] Conference on abuse liability and appeal of tobacco products: Conclusions and recommendations
    Henningfield, Jack E.
    Hatsukami, Dorothy K.
    Zeller, Mitch
    Peters, Ellen
    DRUG AND ALCOHOL DEPENDENCE, 2011, 116 (1-3) : 1 - 7
  • [2] Assessment of Abuse Liability and Nicotine Pharmacokinetics of glo Heated Tobacco Products in a Randomized, Crossover Study
    Kanobe, Milly N.
    Makena, Patrudu
    Prevette, Kristen
    Baxter, Sarah A.
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2024, 49 (06) : 733 - 750
  • [3] Abuse Liability Assessment of Tobacco Products Including Potential Reduced Exposure Products
    Carter, Lawrence P.
    Stitzer, Maxine L.
    Henningfield, Jack E.
    O'Connor, Rich J.
    Cummings, K. Michael
    Hatsukami, Dorothy K.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (12) : 3241 - 3262
  • [4] Abuse liability assessment of hydrocodone under current draft regulatory guidelines
    Gauvin, David V.
    McComb, Margaret
    Code, Robert
    Dalton, Jill A.
    Baird, Theodore J.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2015, 75 : 118 - 129
  • [5] Preclinical assessment of abuse liability of biologics: In defense of current regulatory control policies
    Gauvin, David V.
    Zimmermann, Zachary J.
    Baird, Theodore J.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2015, 73 (01) : 43 - 54
  • [6] Subjective effects of the nicotine lozenge: assessment of abuse liability
    Elisabeth J. Houtsmuller
    Jack E. Henningfield
    Maxine L. Stitzer
    Psychopharmacology, 2003, 167 : 20 - 27
  • [7] Subjective effects of the nicotine lozenge: assessment of abuse liability
    Houtsmuller, EJ
    Henningfield, JE
    Stitzer, ML
    PSYCHOPHARMACOLOGY, 2003, 167 (01) : 20 - 27
  • [8] An abuse liability assessment of the glo tobacco heating product in comparison to combustible cigarettes and nicotine replacement therapy
    George Hardie
    Nathan Gale
    Michael McEwan
    Stefano Milleri Oscar
    Luigi Ziviani
    Christopher J. Proctor
    James Murphy
    Scientific Reports, 12
  • [9] An abuse liability assessment of the glo tobacco heating product in comparison to combustible cigarettes and nicotine replacement therapy
    Hardie, George
    Gale, Nathan
    McEwan, Michael
    Oscar, Stefano Milleri
    Ziviani, Luigi
    Proctor, Christopher J.
    Murphy, James
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [10] Nicotine nasal spray and vapor inhaler: Abuse liability assessment
    Schuh, KJ
    Schuh, LM
    Henningfield, JE
    Stitzer, ML
    PSYCHOPHARMACOLOGY, 1997, 130 (04) : 352 - 361